[1］ Carmina E, Rosato F, Jannì A, et al.Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism［J］. J Clin Endocrinol Metab, 2006,91(1): 2-6.

[2］ Diamanti-Kandarakis E, Panidis D.Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS［J］. Clin Endocrinol (Oxf), 2007, 67(5): 735-742.

[3］ Azziz R, Sanchez LA, Knochenhauer ES, et al.Androgen excess in women: experience with over 1000 consecutive patients［J］. J Clin Endocrinol Metab, 2004,89(2): 453-462.

[4］ 赵君利.汉族育龄多囊卵巢综合征患者的临床特征及分析［J］. 中华妇产科杂志, 2006,41(6): 5.

[5］ Xu X, Shi Y, Cui Y,et al.Endocrine and metabolic characteristics of polycystic ovary syndrome in Chinese women with different phenotypes［J］. Clin Endocrinol (Oxf), 2012,76(3): 425-430.

[6］ Azziz R, Carmina E, Dewailly D,et al.The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report［J］. Fertil Steril, 2009,91(2): 456-488.

[7］ DeUgarte CM, Woods KS, Bartolucci AA, et al.Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism［J］. J Clin Endocrinol Metab, 2006,91(4): 1345-1350.

[8］ Wijeyaratne CN, Balen AH, Barth JH, et al.Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference? ［J］.Clin Endocrinol (Oxf), 2002, 57(3): 343-350.

[9］ Carmina E, Lobo RA.Do hyperandrogenic women with normal menses have polycystic ovary syndrome? ［J］. Fertil Steril, 1999,71(2): 319-322.

[10］ Jonard S, Robert Y, Cortet-Rudelli C,et al.Ultrasound examination of polycystic ovaries: is it worth counting the follicles? ［J］. Hum Reprod, 2003,18(3):598-603.

[11］ Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome［J］. Fertil Steril, 2004, 81(1): 19-25.

[12］ Carmina E, Orio F, Palomba S,et al.Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters［J］. Fertil Steril, 2005,84(2): 413-419.

[13］ Lowe P,Kovacs G, Howlett D.Incidence of polycystic ovaries and polycystic ovary syndrome amongst women in Melbourne, Australia［J］. Aust N Z J Obstet Gynaecol, 2005,45(1): 17-19.

[14］ Hassan MA,Killick SR.Ultrasound diagnosis of polycystic ovaries in women who have no symptoms of polycystic ovary syndrome is not associated with subfecundity or subfertility［J］. Fertil Steril, 2003, 80(4): 966-975.

[15］ Adams JM, Taylor AE, Crowley WF Jr, et al.Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome［J］. J Clin Endocrinol Metab, 2004, 89(9): 4343-4350.

[16］ Carmina E, Wong L, Chang L,et al., Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound［J］. Hum Reprod, 1997,12(5): 905-909.

[17］ Chang PL, Lindheim SR, Lowre C, et al., Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing［J］. J Clin Endocrinol Metab, 2000,85(3): 995-1000.

[18］ Rodin DA, Bano G, Bland JM, et al.Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women［J］. Clin Endocrinol (Oxf), 1998,49(1): 91-99.

[19］ Chan CC, Ng EH, Tang OS, et al., The prevalence of polycystic ovaries in Chinese women with a history of gestational diabetes mellitus［J］. Gynecol Endocrinol, 2006,22(9): 516-520.

[20］ Legro RS, Bentley-Lewis R, Driscoll D, et al.Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity［J］. J Clin Endocrinol Metab, 2002,87(5): 2128-2133.

[21］ Galazis N, Iacovou C, Haoula Z, et al., Metabolomic biomarkers of impaired glucose tolerance and type 2 diabetes mellitus with a potential for risk stratification in women with polycystic ovary syndrome［J］. Eur J Obstet Gynecol Reprod Biol, 2012, 160(2): 121-130.

[22］ Katsikis I, Karkanaki A, Misichronis G, et al.Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome［J］. Eur J Obstet Gynecol Reprod Biol, 2011,156(2): 181-185.

[23］ Srouji SS, Pagán YL, D'Amato F,et al.Pharmacokinetic factors contribute to the inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome［J］. J Clin Endocrinol Metab, 2007, 92(4): 1347-1352.